Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome

Hepatology

Volumn 28, Issue 3, 1998, Pages 638-645

  Wiesner, Russell H ^a   Demetris, A Jake ^b   Belle, Steven H ^c   Seaberg, Eric C ^c   Lake, John R ^d   Zetterman, Rowen K ^e   Everhart, James ^f   Detre, Katherine M ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CREATININE; CYCLOSPORIN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGE; ALLOGRAFT; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; ORGAN DONOR; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 0031783251     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280306     Document Type: Article

References (21)

1. Belle SH, Beringer KC, Dette KM. An update in liver transplantation in the United States: recipient characteristics and outcome. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratories 1996:19-33.
2. Asfar S, Metrakos P, Fryer J, Verran D, Ghent C, Grant D, Bloch M, et al. An analysis of late deaths after liver transplantation. Transplantation 1996;61:1377-1381.
3. Wiesner RH, Ludwig J, van Hoek B, Krom RAE Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. HEPATOLOGY 1991;14:721-729.
4. The U.S. Multicenter FK506 Liver Study Group. A comparison of Tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-1115.
5. Klintmalm GB, Nery JR. Husberg ES, Gonwa TA, Tillery GW. Rejection in liver transplantation. HEPATOLOGY 1989;10:978-985.
6. Datta-Gupta S, Hudson M, Burroughs AK, Morris R, Rolles K, Amlot P, Scheuer PJ, et al. Grading of cellular rejection after orthotopic liver transplantation. HEPATOLOGY 1995;21:46-57.
7. Demetris AJ, Belle SH, Hart J, Lewin K, Ludwig J, Snover D, Tillery GW, et al. Inlraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. HEPATOLOGY 1991;14:751-755.
8. International Working Party. Terminology for hepatic allograft rejection. HEPATOLOGY 1995;22:648-654.
9. Demetris AJ, Seaberg EC, Batts KP, Ferrell LD, Ludwig J, Markin RS, Belle SH, et al. Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases liver transplantation database nomenclature and grading system for cellular rejection of liver allografts. HEPATOLOGY 1995;21:408-416.
10. Wei YL, Detre KM, Everhart JE for the NIDDK Liver Transplantation Database. The NIDDK Liver Transplantation Database. Liver Transplantation and Surgery 1997;3:10-22.
11. Demetris AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, Hart J, et al. Banff Schema for grading liver allograft rejection: an International Consensus Document. HEPATOLOGY 1997;25:658-663.
12. Wiesner RH. Is hepatic histology the true gold standard in diagnosing acute hepatic allograft rejection? Liver Transplantation and Surgery 1996;2:165-167.
13. Millis JM, Woodle SE, Piper JB, Brace DS, Newell KA, Seaman DS, Baker AL, et al. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation 1996;61:1365-1369.
14. Klintmalm GB, Goldstein R, Gomva T, Wiesner RH, Krom RA, Shaw BW Jr, Stratta R, et al. Use of FK506 as rescue therapy for refractory rejection after liver transplantation. Transplant Proc 1993;25:679-688.
15. McDiarmid SV, Klintmalm GB, Busuttil RW. FK506 conversion for intractable rejection of the liver allograft. Transpl Int 1993;6:305-308.
16. Klintmalm GB, Ascher NL, Busuttil RW, Deierhoi M, Gonwa TA, Kauffman R, McDiarmid S, et al. RS-61443 for treatment of resistant human liver rejection. Transplant Proc 1993;25:697.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
18. Kalbfleish JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons, 1980.
19. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc B 1972;34:187-202.
20. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York: John Wiley and Sons, 1973.
21. Agresti A. Categorical Data Analysis. New York: John Wiley and Sons, 1990.